Philip Morris to sell stake in pharma unit Vectura for $198 million

(Reuters) - Marlboro maker Philip Morris International (NYSE:PM )'s unit Vectura Fertin Pharma said on Tuesday it would sell its subsidiary Vectura Group to Molex Asia Holdings for 150 million pounds ($198.09 million).



The deal also has potential deferred payments of up to 148 million pounds.

($1 = 0.7572 pounds)

Source: Investing.com

Последние публикации
Tesla launches redesigned Model Y in China, seeking to fend off rivals
10.01.2025 - 05:00
Tesla launches updated Model Y in China, starting from $35k
10.01.2025 - 05:00
China's SAIC to deepen cooperation with CATL on battery, overseas expansion
10.01.2025 - 05:00
Analysis-South Korea jet crash puts fast-growing Jeju Air's safety under scrutiny
10.01.2025 - 05:00
Indian shares set for a muted start, with the focus on TCS
10.01.2025 - 05:00
Sunac China shares plunge after liquidation petition filed against developer
10.01.2025 - 05:00
China's Zijin Mining in talks to buy controlling stake in Zangge Mining
10.01.2025 - 05:00
Asia stocks dented by Fed, BOJ rate uncertainty; payrolls data in focus
10.01.2025 - 05:00
Hyundai launches $18,000 EV in Japan to penetrate EV-wary market
10.01.2025 - 05:00
Kinder Morgan shuts two Los Angeles fuel pipelines due to power outages
10.01.2025 - 04:00
South Korea presidential security chief warns against violent attempt to arrest Yoon
10.01.2025 - 04:00
Tesla launches revamped Model Y in China, seeking to fend off rivals
10.01.2025 - 04:00
Musk asks state AGs to auction off OpenAI stake in nonprofit restructuring, sources say
10.01.2025 - 03:00
South Korean presidential security chief to appear for questioning by police on Friday
10.01.2025 - 03:00
Tesla announces revamped Model Y version in China, priced from $35,938
10.01.2025 - 03:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?